eli lilly oral semaglutide Lilly's New GLP-1 Orforglipron Beats In Diabetes Trials; FDA Filing Near StockWatch: Price War Dampens Lilly

Take the first step toward achieving your weight loss goals at our Lakewood-area clinic

A new report from ReturnPro, The GLP-1 Effect, examines the impact weight loss medication such as Ozempic and Wegovy is having on an unexpected corner of the fashion industry: returns

The studys results will complement existing clinical outcomes data from related trials and contribute to a better understanding of semaglutides potential cardiovascular benefits

To be clear, GLP-1s are not FDA-approved for treating these conditions right now, but if more research proves they are safe and effective, they could receive formal approval for these uses (or others) in the future